104 related articles for article (PubMed ID: 26541853)
1. [Progress in studies on the relationship between
Dicer and ovarian tumor].
Zhao H; Shao H; Ma J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Oct; 40(10):1156-60. PubMed ID: 26541853
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of dicer expression in ovarian cancer tissues.
Pampalakis G; Diamandis EP; Katsaros D; Sotiropoulou G
Clin Biochem; 2010 Feb; 43(3):324-7. PubMed ID: 19782670
[TBL] [Abstract][Full Text] [Related]
3. The modulation of Dicer regulates tumor immunogenicity in melanoma.
Hoffend NC; Magner WJ; Tomasi TB
Oncotarget; 2016 Jul; 7(30):47663-47673. PubMed ID: 27356752
[TBL] [Abstract][Full Text] [Related]
4. In vivo structure-function analysis of human Dicer reveals directional processing of precursor miRNAs.
Gurtan AM; Lu V; Bhutkar A; Sharp PA
RNA; 2012 Jun; 18(6):1116-22. PubMed ID: 22546613
[TBL] [Abstract][Full Text] [Related]
5. The oncogenic roles of DICER1 RNase IIIb domain mutations in ovarian Sertoli-Leydig cell tumors.
Wang Y; Chen J; Yang W; Mo F; Senz J; Yap D; Anglesio MS; Gilks B; Morin GB; Huntsman DG
Neoplasia; 2015 Aug; 17(8):650-60. PubMed ID: 26408257
[TBL] [Abstract][Full Text] [Related]
6. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.
Heravi-Moussavi A; Anglesio MS; Cheng SW; Senz J; Yang W; Prentice L; Fejes AP; Chow C; Tone A; Kalloger SE; Hamel N; Roth A; Ha G; Wan AN; Maines-Bandiera S; Salamanca C; Pasini B; Clarke BA; Lee AF; Lee CH; Zhao C; Young RH; Aparicio SA; Sorensen PH; Woo MM; Boyd N; Jones SJ; Hirst M; Marra MA; Gilks B; Shah SP; Foulkes WD; Morin GB; Huntsman DG
N Engl J Med; 2012 Jan; 366(3):234-42. PubMed ID: 22187960
[TBL] [Abstract][Full Text] [Related]
7. β-catenin downregulates Dicer to promote ovarian cancer metastasis.
To SKY; Mak ASC; Eva Fung YM; Che CM; Li SS; Deng W; Ru B; Zhang J; Wong AST
Oncogene; 2017 Oct; 36(43):5927-5938. PubMed ID: 28650464
[TBL] [Abstract][Full Text] [Related]
8. Dicer reprograms stromal fibroblasts to a pro-inflammatory and tumor-promoting phenotype in ovarian cancer.
Yang Z; Jin P; Xu S; Zhang T; Yang X; Li X; Wei X; Sun C; Chen G; Ma D; Gao Q
Cancer Lett; 2018 Feb; 415():20-29. PubMed ID: 29199004
[TBL] [Abstract][Full Text] [Related]
9. The co-occurrence of an ovarian Sertoli-Leydig cell tumor with a thyroid carcinoma is highly suggestive of a DICER1 syndrome.
Durieux E; Descotes F; Mauduit C; Decaussin M; Guyetant S; Devouassoux-Shisheboran M
Virchows Arch; 2016 May; 468(5):631-6. PubMed ID: 26983701
[TBL] [Abstract][Full Text] [Related]
10. Analysis of microRNA length variety generated by recombinant human Dicer.
Starega-Roslan J; Krzyzosiak WJ
Methods Mol Biol; 2013; 936():21-34. PubMed ID: 23007496
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA in cancer prognosis.
Slack FJ; Weidhaas JB
N Engl J Med; 2008 Dec; 359(25):2720-2. PubMed ID: 19092157
[No Abstract] [Full Text] [Related]
12. Suppression of collagen synthesis by Dicer gene silencing in hepatic stellate cells.
Yu F; Lin Z; Zheng J; Gao S; Lu Z; Dong P
Mol Med Rep; 2014 Feb; 9(2):707-14. PubMed ID: 24337369
[TBL] [Abstract][Full Text] [Related]
13. Impaired expression of DICER and some microRNAs in HBZ expressing cells from acute adult T-cell leukemia patients.
Gazon H; Belrose G; Terol M; Meniane JC; Mesnard JM; Césaire R; Peloponese JM
Oncotarget; 2016 May; 7(21):30258-75. PubMed ID: 26849145
[TBL] [Abstract][Full Text] [Related]
14. The many faces of Dicer: the complexity of the mechanisms regulating Dicer gene expression and enzyme activities.
Kurzynska-Kokorniak A; Koralewska N; Pokornowska M; Urbanowicz A; Tworak A; Mickiewicz A; Figlerowicz M
Nucleic Acids Res; 2015 May; 43(9):4365-80. PubMed ID: 25883138
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression.
Rupaimoole R; Ivan C; Yang D; Gharpure KM; Wu SY; Pecot CV; Previs RA; Nagaraja AS; Armaiz-Pena GN; McGuire M; Pradeep S; Mangala LS; Rodriguez-Aguayo C; Huang L; Bar-Eli M; Zhang W; Lopez-Berestein G; Calin GA; Sood AK
Oncogene; 2016 Aug; 35(33):4312-20. PubMed ID: 26725326
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of dicer as a result of reduced let-7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells.
Jakymiw A; Patel RS; Deming N; Bhattacharyya I; Shah P; Lamont RJ; Stewart CM; Cohen DM; Chan EK
Genes Chromosomes Cancer; 2010 Jun; 49(6):549-59. PubMed ID: 20232482
[TBL] [Abstract][Full Text] [Related]
17. Dicing the Disease with Dicer: The Implications of Dicer Ribonuclease in Human Pathologies.
Theotoki EI; Pantazopoulou VI; Georgiou S; Kakoulidis P; Filippa V; Stravopodis DJ; Anastasiadou E
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33007856
[TBL] [Abstract][Full Text] [Related]
18. Design of Multimodal Small Molecules Targeting miRNAs Biogenesis: Synthesis and In Vitro Evaluation.
Vo DD; Duca M
Methods Mol Biol; 2017; 1517():137-154. PubMed ID: 27924480
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-581 promotes hepatitis B virus surface antigen expression by targeting Dicer and EDEM1.
Wang YQ; Ren YF; Song YJ; Xue YF; Zhang XJ; Cao ST; Deng ZJ; Wu J; Chen L; Li G; Shi KQ; Chen YP; Ren H; Huang AL; Tang KF
Carcinogenesis; 2014 Sep; 35(9):2127-33. PubMed ID: 24913918
[TBL] [Abstract][Full Text] [Related]
20. Conditional Deletion of Dicer in Adult Mice Impairs Skeletal Muscle Regeneration.
Oikawa S; Lee M; Akimoto T
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
